Screening the publicly available cBioportal cancer genome database38,39 for cancers with alterations in Phafin2 showed that Phafin2 is frequently amplified across multiple cancers, whereas deletions are very rare (Fig. 8d, e). This evidence concerns the gene PLEKHF2 and cancer.